Increased proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in people with HIV may be related to abnormal coronary endothelial function.
ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) was utilized to identify all patients who received HCV treatment for at least 7 weeks as well as a propensity-score matched group who did not receive treatment.
Patients recovering from sepsis had an elevated risk for myocardial infarction or stroke in the first 4 weeks after hospital discharge compared to the general population.
Elderly patients who have been inoculated with the influenza vaccine and who also use a statin are at a greater risk for medically attended acute respiratory illness.
Women with high-risk human papillomavirus are at higher risk for developing cardiovascular disease than women without high-risk HPV
Treatment for hepatitis C is associated with a reduction in cardiovascular events.
The week 96 results of the DRIVE-AHEAD phase 3 noninferiority trial support noninferiority of doravirine to efavirenz in treatment-naive adults with HIV-1.
Exposure to abacavir is associated with an increased risk for cardiovascular disease in individuals infected with HIV.
Carotid artery plaque was predictive of mortality, with differences observed by sex and HIV serostatus.
Immediate and deferred switching from a boosted protease inhibitor to a dolutegravir regimen in HIV + patients is found to be highly efficacious.
Bilirubin appeared to be inversely associated with cardiovascular disease in individuals with HIV enrolled in the Veterans Aging Cohort Study.
The Copenhagen Co-morbidity in HIV Infection (COCOMO) study assessed the association between risk factors for cardiovascular disease and HIV infection.
A meta-analysis sought to determine the effect of influenza vaccination on cardiac-related mortality in patients with heart failure.
Community-acquired pneumonia and other acute infections can cause or exacerbate cardiovascular complications.
Findings confirm that cardiovascular complications related to commonly-administered, live viral vaccination are rare in adults.
HCV eradication by DAA improves carotid atherosclerosis in patients with advanced fibrosis and compensated cirrhosis.
Undergoing cardiac surgery during the influenza season is associated with increased risk of ARDS.
The recommendation was made after the FDA reviewed the results of a 10-year follow-up of the CLARICOR trial, which investigated the effects of clarithromycin in patients with stable coronary heart disease.
In a self-controlled case series, patients were observed to have increased incidence of hospital admissions for acute myocardial infarction within 7 days of respiratory virus detection.
A new study sought to qualify the adherence to evidence-based cardiovascular care guidelines for patients living with HIV.
HIV-infected people with unsuppressed HIV virus or low CD4 cell counts had a higher prevalence of increased pulmonary artery systolic pressure than uninfected people.
Findings show that HIV status was associated with an increased rate of incidental carotid plaque, noncalcified plaque, and high-risk plaque.
Abacavir-containing antiretroviral therapy does not appear to confer an increased risk for myocardial infarction or coronary artery disease.
Traditional risk factors may incur a higher risk for CVD in HIV-positive premenopausal women than HIV infection itself.
Cardiovascular disease risks persist for years after sepsis or pneumonia.
Epidemiological data demonstrate a link between HCV infection and cardiovascular disease, whereas treatment studies suggest viral eradication may lower the risk for cardiovascular morbidity and mortality.
Dobutamine stress perfusion echocardiography can detect microvascular perfusion abnormalities that predict cardiovascular outcomes in candidates for liver transplantation.
Risk of acute myocardial infarction is 17 times higher after respiratory infection.
Pitavastatin reduced low-density lipoprotein cholesterol to a greater extent than pravastatin with a similar safety profile in patients with HIV and dyslipidemia.
Patients who took azithromycin weren't any more likely to develop ventricular arrhythmia than those taking amoxicillin.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Novel H pylori Eradication Therapy Effective in Phase 3 Trial
- Polymyxin B Hemoperfusion Does Not Change Mortality Rate in Septic Shock
- New Four Drug Regimen Effective in Patients With HCV Who Inject Drugs
- Pediatric ART Leads to Increasing Mitochondrial DNA Mutations
- Prior Influenza Vaccination Not Associated With Future Vaccine Efficacy in Children